Not good... Massive impairment and the CEO sold 867,000 shares! Underlying results (EBITDA and EPS) aren't horrific but the report does a terrible job of explaining that.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game